Log | Progress In Mind

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:cmmoreal@gmail.com	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:cgrpsiq@hotmail.com	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:CARLA.RIBS@HOTMAIL.COM	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:waldemar.barboza@gmail.com	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:cristina.r.marques@gmail.com	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:frandalf@hotmail.com	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:auxiliadoraviana@gmail.com	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:keronlainy@hotmail.com	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter sending	Tue, 07/21/2020 - 22:00	Sending to 4723	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 2		Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Brazil newsletter		Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Brazil newsletter		Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Estratégias na esquizofrenia - Aderente à adesão	Anonym
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://za.progress.im/en/content/what-are-roles-abnormal-metabolism-and-inflammation-mood-disorders		Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonym
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind South Africa		Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Convite Lundbeck Webinar Internacional	Anonym
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Brazil newsletter		Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym

Log Type	Authored on	Log Message	Log Node	Authored by
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:cmmoreal@gmail.com	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:cgrpsiq@hotmail.com	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:CARLA.RIBS@HOTMAIL.COM	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:waldemar.barboza@gmail.com	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:cristina.r.marques@gmail.com	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:frandalf@hotmail.com	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:auxiliadoraviana@gmail.com	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter sent to:keronlainy@hotmail.com	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
Newsletter sending	Tue, 07/21/2020 - 22:00	Sending to 4723	Novos medicamentos têm como alvo a CGRP e seus receptores	Anonym
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 2		Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Brazil newsletter		Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Brazil newsletter		Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Estratégias na esquizofrenia - Aderente à adesão	Anonym
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://za.progress.im/en/content/what-are-roles-abnormal-metabolism-and-inflammation-mood-disorders		Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Anonym
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind South Africa		Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Convite Lundbeck Webinar Internacional	Anonym
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Brazil newsletter		Anonym
User created	Wed, 10/12/2022 - 13:23	User created		Anonym

Patrocinado por

Progress in Mind Brazil

INSCRIÇÃO NEWSLETTER